[1]关勇宇,张广润,李海龙,等.黄芪提取物对帕金森病小鼠黑质区白介素-17通路的影响[J].陕西中医杂志,2024,(4):468-472.[doi:DOI:10.3969/j.issn.1000-7369.2024.04.007]
　GUAN Yongyu,ZHANG Guangrun,LI Hailong,et al.Effect of Astragalus extract on IL-17 signaling pathway in substantia nigra of Parkinson's disease mice[J].,2024,(4):468-472.[doi:DOI:10.3969/j.issn.1000-7369.2024.04.007]
点击复制

黄芪提取物对帕金森病小鼠黑质区白介素-17通路的影响
分享到：

《陕西中医》杂志[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2024年4期
页码:
468-472
栏目:
基础研究
出版日期:
2024-04-05

文章信息/Info

Title:
Effect of Astragalus extract on IL-17 signaling pathway in substantia nigra of Parkinson's disease mice
作者:
关勇宇1; 张广润2; 李海龙1; 邵菲菲2
(1.甘肃中医药大学,甘肃 兰州 730000; 2.甘肃省人民医院,甘肃 兰州 730000)
Author(s):
GUAN Yongyu; ZHANG Guangrun; LI Hailong; SHAO Feifei
(Gansu University of Traditional Chinese Medicine,Lanzhou 730000,China)
关键词:
帕金森病;  黄芪提取物;  黑质;  信号通路;  白细胞介素-17;  小鼠
Keywords:
Parkinson's disease;  Astragalus extract;  Substantia nigra;  Signaling pathway;  Interleukin-17;  Mice
分类号:
R 742.5
DOI:
DOI:10.3969/j.issn.1000-7369.2024.04.007
文献标志码:
A
摘要:
目的:探究黄芪提取物干预白介素-17(IL-17)信号通路治疗帕金森病(PD)作用机制。方法:将30只雄性C57BL/6小鼠均分为五组。除对照组之外均采用MPTP诱导PD模型,建模成功后,低、中、高浓度黄芪组分别以50、100、200 mg/kg黄芪提取物持续灌胃14 d,模型组和对照组采用等量0.9%氯化钠溶液灌胃。灌胃后结束后采用转棍实验和爬杆实验评估各组小鼠行为表现。免疫组化法测定各组脑黑质致密区(SNpc)酪氨酸羟化酶(TH)和Th17细胞数目; Western blot测定纹状体区IL-17、抗肿瘤坏死因子受体相关因子6(TRAF6)、核因子-κB(NF-κB)、白介素-1β(IL-1β)、白介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)、环氧合酶-2(COX-2)蛋白相对表达量。结果:与对照组比较,模型组和各浓度黄芪组小鼠转棍掉落潜伏期明显缩短,爬杆实验头向下时间(T1)、由杆顶爬至杆底所用时间(T-LA)明显延长,SNpc区TH表达水平下降,Th17细胞数目增多,纹状体区IL-17、TRAF-6、NF-κB、IL-1β、IL-6、TNF-α、COX-2蛋白相对表达水平明显升高(均P<0.05)。与模型组比较,各浓度黄芪组小鼠转棍掉落潜伏期明显延长,爬杆实验T1和T-LA明显缩短,SNpc区TH表达水平升高,Th17细胞数目减少,纹状体区IL-17、TRAF-6、NF-κB、IL-1β、IL-6、TNF-α、COX-2蛋白相对表达水平明显下降(均P<0.05),且与黄芪提取物浓度呈正相关。结论:黄芪提取物能有效改善PD模型小鼠转棍和爬杆活动能力,保护SNpc区TH阳性神经元,其机制可能与抑制IL-17/TRAF-6/NF-κB信号通路,减少多巴胺神经元炎症性损伤凋亡有关。
Abstract:
Objective:To explore the therapeutic effect of astragalus extract on Parkinson's disease(PD)by intervening the interleukin-17(IL-17)signaling pathway.Methods:30 male C57BL/6 mice were divided into 5 groups.Except the control group,MPTP was used to induce PD model.After successful modeling,the low,medium and high concentration groups were given 50,100 and 200 mg/kg Astragalus extract for 14 days,respectively.And model group and control group were given the same amount of normal saline.After the end of intragastric administration,the behavior of each group of mice was evaluated by rotating stick test and climbing pole test.The numbers of tyrosine hydroxylase(TH)and Th17 cells in the dense region of substantia nigra(SNpc)were determined by immunohistochemistry.Western blot assay was used to determine the protein phases of IL-17,anti-tumor necrosis factor receptor-associated factor 6(TRAF6),nuclear factor-κB(NF-κB),interleukin-1β(IL-1β),interleukin-6(IL-6),tumor necrosis factor-α(TNF-α),and anti-cyclooxygenase-2(COX-2)in the striate body region on the amount of expression.Results:Compared with the control group,the incubation period of mice in model group and Astragalus group was significantly shortened,the times of T1 and T-LA were significantly prolonged,TH expression level in SNpc region decreased,and Th17 cell number increased,the relative expression levels of IL-17,TRAF-6,NF-κB,IL-1β,IL-6,TNF-α and COX-2 proteins in striatum were significantly increased(all P<0.05).Compared with model group,the incubation period of mice in Astragalus group was significantly prolonged,the times of T1 and T-LA were significantly shortened,TH expression level in SNpc region was increased,and the number of Th17 cells was decreased,and the relative expression levels of IL-17,TRAF-6,NF-κB,IL-1β,IL-6,TNF-α and COX-2 proteins in striatum were significantly decreased(all P<0.05).The levels of all observation indexes in Astragalus group were significantly correlated with the concentration of Astragalus extract.Conclusion:Astragalus extract can effectively improve stick-turning and stick-climbing activity of PD model mice,and protect TH-positive neurons in SNpc region,which may be related to inhibiting IL-17/TRAF-6/NF-κB signaling pathway and reducing inflammatory damage of dopamine neurons.

参考文献/References:

[1] 席晓明,毕鸿雁.腹部扭转运动对帕金森病患者抑郁、便秘、运动症状和生活质量的效果[J].中国康复理论与实践,2022,28(2):220-226.
[2] SIMON D K,TANNER C M,BRUNDIN P.Parkinson disease epidemiology,pathology,genetics,and pathophysiology[J].Clin Geriatr Med,2020,36(1):1-12.
[3] KUMAR S,GOYAL L,SINGH S.Tremor and rigidity in patients with parkinson's disease:Emphasis on epidemiology,pathophysiology and contributing factors[J].CNS Neurol Disord Drug Targets,2022,21(7):596-609.
[4] 中华医学会神经病学分会帕金森病及运动障碍学组,中国医师协会神经内科医师分会帕金森病及运动障碍学组.中国帕金森病治疗指南(第四版)[J].中华神经科杂志,2020,53(12):973-986.
[5] 刘川,李环,王大伟.霍山石斛多糖对帕金森病模型小鼠脑组织氧化应激和炎症反应的影响[J].吉林大学学报(医学版),2023,49(1):110-115.
[6] 陈薪旭,王埮,张填.粪菌移植对慢性帕金森病小鼠模型黑质区炎症反应的影响[J].中国老年学杂志,2022,42(19):4778-4783.
[7] 张钧柔,张诗玄,李婕,等.白细胞介素-17信号通路在锰中毒及相关的神经退行性疾病中作用的生物信息学研究[J].环境与职业医学,2022,39(10):1140-1145.
[8] 袁月松,王兴臣,姬琳,等.名中医王兴臣从脾胃论治帕金森病经验[J].陕西中医,2022,43(11):1605-1608,1612.
[9] 侯可可,陈琳,沙雯君,等.黄芪及其提取物治疗糖尿病心肌病的药理机制研究进展[J].环球中医药,2023,16(5):1036-1043.
[10] 张天琪,李传成,张铁峰,等.基于网络药理学和体外实验探讨黄芪甲苷通过激活PI3K/AKT信号通路减轻PC12细胞损伤的作用机制[J].中国中药杂志,2021,46(24):6465-6473.
[11] 邢家玮,陈红,余占海,等.黄芪多糖对荷腹水瘤小鼠氧化应激功能的影响[J].中国临床药理学杂志,2022,38(9):970-973,988.
[12] 李彦荣,刘光炜,赵晶.我国黄芪药理学研究的文献学分析[J].西部中医药,2019,32(2):86-89.
[13] 任炜霞,刘毅,武前福,等.基于调控小胶质细胞探讨中医药治疗帕金森病机制[J].陕西中医,2023,44(3):341-344.
[14] 高天阔,秦晋中,肇玉明.丹参有效成分治疗帕金森病的研究[J].脑与神经疾病杂志,2023,31(6):392-396.
[15] 霍洁,张进禄,郭伟.大鼠纹状体炎症诱导黑质多巴胺能神经元变性研究[J].中国急救医学,2017,37(6):551-555.
[16] 刘斌,杨浩辉,任伯,等.丁苯酞联合美多芭对帕金森病伴抑郁模型小鼠黑质纹状体Ⅱ型髓系细胞触发受体及小胶质细胞炎症标志物表达的影响[J].陕西医学杂志,2022,51(12):1477-1482.
[17] 耿广琴,刘坤,夏光萍,等.黄芪与红芪提取物对衰老模型小鼠脑组织抗氧化能力和海马结构功能的影响[J].中国现代应用药学,2017,34(4):500-504.
[18] 邢发萍,杨柳,韩欣研,等.黄芪提取物抑制小鼠实验性自身免疫性脑脊髓炎的作用及机制[J].中国药理学与毒理学杂志,2019,33(11):941-948.
[19] 王开达,王兴臣,姬琳.网络药理学预测黄芪治疗帕金森病作用机制及实验验证[J].中国实验方剂学杂志,2020,26(24):178-185.
[20] 黄晓静,黄淮,徐正虎,等.黄芪甲苷改善1-甲基-4-苯基吡啶离子诱导的帕金森病SK-N-SH细胞损伤疗效初探[J].中国现代神经疾病杂志,2022,22(3):155-162.
[21] 周爽,王琰,孙光强,等.过表达5-脂氧合酶通路对氧糖剥夺/复氧小胶质细胞增殖、凋亡的影响[J].陕西医学杂志,2022,51(4):410-414,418.
[22] WILLIAMS G P,SCHONHOFF A M,JURKUVENAITE A,et al.CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of parkinson's disease[J].Brain,2021,144(7):2047-2059.
[23] 张贝蕾,乐道平,林名瑞,等.清瘟败毒饮对脓毒症大鼠心肌组织IL-17信号通路相关基因表达的影响[J].中国中西医结合急救杂志,2021,28(2):141-146.
[24] LUO H,LIU H Z,ZHANG W W,et al.Interleukin-17 regulates neuron-glial communications,synaptic transmission,and neuropathic pain after chemotherapy[J].Cell Rep,2019,29(8):2384-2397.
[25] FENG Z,ZHAN M,MENG R,et al.5-aza-2'-deoxycytidine enhances lipopolysaccharide-induced inflammatory cytokine expression in juman dental pulp cells by regulating TRAF6 methylation[J].Bioengineered,2019,10(1):197-206.
[26] 高岭,陈王璐,陈奕奕,等.针灸对帕金森病小鼠黑质白细胞介素-17受体A/核因子κB信号通路的影响[J].世界中医药,2022,17(18):2580-2586.

相似文献/References:

[1]贺小霞,郭 林,邓晓明.养血益智汤治疗帕金森认知功能障碍疗效及对患者认知功能、日常生活能力的影响[J].陕西中医杂志,2019,(1):31.
[2]王英淑,彭建东△,阮世琪,等.头针长留针配合运动疗法对早期帕金森患者运动功能的影响*[J].陕西中医杂志,2019,(8):1124.
　WANG Yingshu,PENG Jiandong,RUAN Shiqi,et al.Effects of scalp acupuncture by retaining long time combined with exercise therapy on motor function of patients with early Parkinson ’s disease[J].,2019,(4):1124.
[3]吴成举,英锡相,陈 靖,等.针刺疗法对帕金森病大鼠黑质神经元凋亡蛋白bcl2、bax的影响*[J].陕西中医杂志,2020,(1):8.
　WU Chengju,YING Xixiang,CHEN Jing,et al.Effect of acupuncture on apoptosis protein bcl2 and bax 〖JZ〗in substantia nigra neurons of Parkinson’s disease model rats[J].,2020,(4):8.
[4]李伦甘,胡玉英.中医药干预对帕金森病细胞凋亡影响的研究进展[J].陕西中医杂志,2021,(2):262.[doi:DOI:10.3969/j.issn.1000-7369.2020.02.031]
[5]宋 杰,杨言府.益肾宁心汤加减治疗帕金森病合并睡眠障碍临床研究[J].陕西中医杂志,2021,(6):747.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.017]
[6]马振旺,梁 浩,赵 兵,等.透穴刺法对帕金森病焦虑大鼠杏仁核TNF-α和IL-10表达的影响[J].陕西中医杂志,2021,(9):1171.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.005]
　MA Zhenwang,LIANG Hao,ZHAO Bing,et al.Effect of acupoint piercing on expression of TNF-α and IL-10 in amygdala of anxious rats with Parkinson's disease[J].,2021,(4):1171.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.005]
[7]黄金玉,刘智斌.四海取穴论治帕金森病研究进展[J].陕西中医杂志,2022,(6):811.[doi:DOI:10.3969/j.issn.1000-7369.2022.06.033]
　HUANG Jinyu,LIU Zhibin.Research progress on Parkinson's disease by acupoint selection of Sihai[J].,2022,(4):811.[doi:DOI:10.3969/j.issn.1000-7369.2022.06.033]
[8]袁月松,王兴臣,姬 琳,等.名中医王兴臣从脾胃论治帕金森病经验[J].陕西中医杂志,2022,(11):1605.[doi:DOI:10.3969/j.issn.1000-7369.2022.11.027]
　YUAN Yuesong,WANG Xingchen,JI Lin,et al.Professor WANG Xingchen's experience in treating parkinson's disease from the spleen and stomach[J].,2022,(4):1605.[doi:DOI:10.3969/j.issn.1000-7369.2022.11.027]
[9]任炜霞,刘 毅,武前福,等.基于调控小胶质细胞探讨中医药治疗帕金森病机制[J].陕西中医杂志,2023,(3):341.[doi:DOI:10.3969/j.issn.1000-7369.2023.03.016]
[10]杨静棉.补肾健脾方改善帕金森病患者非运动症状和血清细胞因子水平临床研究[J].陕西中医杂志,2023,(4):451.[doi:DOI:10.3969/j.issn.1000-7369.2023.04.009]
　YANG Jingmian.Clinical study of Bushen Jianpi decoction to improve non-motor symptoms and serum cytokine levels in patients with parkinson's disease[J].,2023,(4):451.[doi:DOI:10.3969/j.issn.1000-7369.2023.04.009]

备注/Memo

备注/Memo:
基金项目:甘肃省青年科技基金资助项目(21JR7RA652)
更新日期/Last Update: 2024-04-10